616 related articles for article (PubMed ID: 9880474)
1. Current and emerging azole antifungal agents.
Sheehan DJ; Hitchcock CA; Sibley CM
Clin Microbiol Rev; 1999 Jan; 12(1):40-79. PubMed ID: 9880474
[TBL] [Abstract][Full Text] [Related]
2. Azole antifungal agents.
Bodey GP
Clin Infect Dis; 1992 Mar; 14 Suppl 1():S161-9. PubMed ID: 1314105
[TBL] [Abstract][Full Text] [Related]
3. Second-generation azole antifungal agents.
Kale P; Johnson LB
Drugs Today (Barc); 2005 Feb; 41(2):91-105. PubMed ID: 15821782
[TBL] [Abstract][Full Text] [Related]
4. Azole antifungal drugs: old and new.
Dismukes WE
Ann Intern Med; 1988 Aug; 109(3):177-9. PubMed ID: 2839058
[No Abstract] [Full Text] [Related]
5. Oral azole drugs as systemic antifungal therapy.
Como JA; Dismukes WE
N Engl J Med; 1994 Jan; 330(4):263-72. PubMed ID: 8272088
[TBL] [Abstract][Full Text] [Related]
6. New antifungal agents.
Graybill JR
Eur J Clin Microbiol Infect Dis; 1989 May; 8(5):402-12. PubMed ID: 2546775
[TBL] [Abstract][Full Text] [Related]
7. Azole antifungals: 35 years of invasive fungal infection management.
Allen D; Wilson D; Drew R; Perfect J
Expert Rev Anti Infect Ther; 2015 Jun; 13(6):787-98. PubMed ID: 25843556
[TBL] [Abstract][Full Text] [Related]
8. Azole antifungal agents: emphasis on new triazoles.
Saag MS; Dismukes WE
Antimicrob Agents Chemother; 1988 Jan; 32(1):1-8. PubMed ID: 2831809
[TBL] [Abstract][Full Text] [Related]
9. Small molecules restore azole activity against drug-tolerant and drug-resistant
Alabi PE; Gautier C; Murphy TP; Gu X; Lepas M; Aimanianda V; Sello JK; Ene IV
mBio; 2023 Aug; 14(4):e0047923. PubMed ID: 37326546
[TBL] [Abstract][Full Text] [Related]
10. Voriconazole: therapeutic review of a new azole antifungal.
Herbrecht R
Expert Rev Anti Infect Ther; 2004 Aug; 2(4):485-97. PubMed ID: 15482215
[TBL] [Abstract][Full Text] [Related]
11. Antifungal resistance in superficial mycoses.
Gupta AK; Venkataraman M
J Dermatolog Treat; 2022 Jun; 33(4):1888-1895. PubMed ID: 34132155
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in the treatment of systemic fungal infections.
Walsh TJ
Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):769-78. PubMed ID: 2834615
[TBL] [Abstract][Full Text] [Related]
13. Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy.
Troke PF; Andrews RJ; Pye GW; Richardson K
Rev Infect Dis; 1990; 12 Suppl 3():S276-80. PubMed ID: 2184505
[TBL] [Abstract][Full Text] [Related]
14. History of the development of azole derivatives.
Maertens JA
Clin Microbiol Infect; 2004 Mar; 10 Suppl 1():1-10. PubMed ID: 14748798
[TBL] [Abstract][Full Text] [Related]
15. Interaction of azoles with rifampin, phenytoin, and carbamazepine: in vitro and clinical observations.
Tucker RM; Denning DW; Hanson LH; Rinaldi MG; Graybill JR; Sharkey PK; Pappagianis D; Stevens DA
Clin Infect Dis; 1992 Jan; 14(1):165-74. PubMed ID: 1315160
[TBL] [Abstract][Full Text] [Related]
16. [Emerging azole antifungals].
Wolff M; Bouadma L; Mourvillier B
Therapie; 2006; 61(3):227-33. PubMed ID: 16989123
[TBL] [Abstract][Full Text] [Related]
17. Azole drug resistance in yeasts.
Johnson EM; Warnock DW
J Antimicrob Chemother; 1995 Nov; 36(5):751-5. PubMed ID: 8626255
[No Abstract] [Full Text] [Related]
18. New antifungal agents.
Gupta AK; Tomas E
Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
[TBL] [Abstract][Full Text] [Related]
19. Medically important fungi respond to azole drugs: an update.
Zavrel M; White TC
Future Microbiol; 2015; 10(8):1355-73. PubMed ID: 26234644
[TBL] [Abstract][Full Text] [Related]
20. The evolution of azole compounds in antifungal chemotherapy.
Borgers M
J Chemother; 1989 Jul; 1(4 Suppl):238-40. PubMed ID: 16312384
[No Abstract] [Full Text] [Related]
[Next] [New Search]